© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 18, 2021
Investigators called for prospective studies with longer time horizons to see if these associations persist throughout childhood.
To the investigators’ knowledge, the study offers insights into lesion presentations on undiagnosed adults with vitiligo.
November 16, 2021
Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.
Respondents suggested that increasing product availability and demonstrating the consequences of sunburn could increase sun protection among young people.
November 15, 2021
Dr. Elewski hopes that in the future more clinicians will prescribe biologics such as secukinumab and etancercept for the treatment of psoriasis.
Though not all hemangioma last past 10 years old in pediatric patients, some untreated hemangioma are associated with high risk of ulceration.
Though Dr. Khattri felt the diagnosis of psoriatic arthritis had been “stagnant”, the inclusion of biologic therapies and more has been a welcomed change.
Certain biologics such as infliximab have aided psoriasis patients in the mitigation of symptoms from the COVID-19 virus.
Dr. Swanson also details the effects of the COVID-19 pandemic on her practice with the implementation of telemedicine.
Dr. Desai says that Janus kinase inhibitors present a new mechanism of action, with effects on cytokine signals that signal inflammation in atopic diseases.
Biosimilar SB15 Indicates Equivalent Efficacy to Aflibercept in nAMD Treatment
Rare Immunodeficiency Treatment Receives FDA Priority Review
Research Suggests Low Bone Mineral Density Linked to Epidermolysis Bullosa